The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation.
Jiang W, Kim S, Zhang X, Lionberger RA, Davit BM, Conner DP, Yu LX.
Jiang W, et al.
Int J Pharm. 2011 Oct 14;418(2):151-60. doi: 10.1016/j.ijpharm.2011.07.024. Epub 2011 Jul 23.
Int J Pharm. 2011.
PMID: 21803144
These applications include, but are not limited to: the development of biorelevant specifications, the determination of bioequivalence metrics for modified release products with rapid therapeutic onset, the design of in vitro-in vivo correlations …
These applications include, but are not limited to: the development of biorelevant specifications, the determination of bioequivalenc …